TomVBerghe Profile Banner
Tom Vanden Berghe Profile
Tom Vanden Berghe

@TomVBerghe

Followers
513
Following
1K
Media
36
Statuses
332

Expert in Cell death and Disease

BELGIUM
Joined August 2011
Don't wanna be here? Send us removal request.
@TomVBerghe
Tom Vanden Berghe
3 months
📰 New paper alert! In case you missed it over the holidays: my News & Views on the latest work from the Linkermann Lab is out. https://t.co/5rbQPIRfkg Congrats to the Linkermann team on this exciting study! 🎉 #ScienceTwitter #CellDeath #Research @Nature https://t.co/WO9mvtmNhh
Tweet card summary image
nature.com
Nature - Differences in protection against ferroptosis explain why men and postmenopausal women are more susceptible than premenopausal women to acute kidney injury.
0
0
6
@TomVBerghe
Tom Vanden Berghe
4 months
Game changer in translational ferroptosis research. Check out this nature paper by Linkermann lab and his amazing team ! Oestrogen defends against kidney damage caused by iron-dependent cell death
Tweet card summary image
nature.com
Nature - Differences in protection against ferroptosis explain why men and postmenopausal women are more susceptible than premenopausal women to acute kidney injury.
0
7
19
@TomVBerghe
Tom Vanden Berghe
7 months
Mads Daugaard is striking again. High level of translational oncology presented @EWCD meeting in Fiuggi Italy.
0
0
3
@ECDOorg
ECDO
7 months
Registration for ECDO2025 is now officially open. Secure your place at the legendary event in Berlin today https://t.co/ib8ZfyHWFB
0
3
5
@ECDOorg
ECDO
8 months
⚡️SAVE the DATE!!!! SAVE the DATE!!!!⚡️
@ECDOorg
ECDO
10 months
📣Save the date 📣 ECDO 2025 Conference in Berlin 7-10 October 2025 📆
0
4
12
@BMCBiology
BMC Biology
9 months
Harnessing ferroptosis for precision oncology: challenges and prospects. New #openaccess Review from Fernández-Acosta @TomVBerghe and co as part of our ‘#Ferroptosis’ Collection https://t.co/ptWWwNPbXP
0
2
2
@ThePhDPlace
The PhD Place
11 months
This is such an accurate representation of being a PhD student
12
97
761
@fabiomartinon
Fabio Martinon
11 months
🚀 Exciting opportunity! 🎓 The PhD program in Cancer and Immunology in Lausanne is accepting applications! If you're passionate about advancing research in cancer or immunology, we want to hear from you! 🌟 #PhD #CancerResearch #Immunology https://t.co/o4VYUw0oyS via @unil
unil.ch
Page Cancer and Immunology of site Home hosted by the University of Lausanne
1
17
22
@EricTopol
Eric Topol
1 year
The human proteomic revolution proceeds with high-throughput assessment, AI analytics, correlation with health and disease, drug interactions, biomarkers https://t.co/VsYD6vGxXp
6
192
664
@harveyjberger
Harvey J. Berger, M.D.
1 year
While at @DanaFarber, Brian Bruker (now @OHSUKnight) started the personalized medicine revolution with the first targeted cancer drug, imatinib. The first of a series of BCR-ABL inhibitors that made Ph+ #CML a chronic disease. A transformative discovery.
@nihardesai7
𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM
1 year
23 years ago, the FDA approved a drug that changed the life of millions of patients with chronic myeloid leukemia 💪🏼 Thank you Dr. Druker 🙏🏼 Thank you imatinib 🙏🏼 #MedTwitter
0
2
4
@TomVBerghe
Tom Vanden Berghe
1 year
Interested in our work? Watch 'Knappe koppen' on national TV VRT1 Wednesday Dec 4 at 21h35. Geinteresseerd in ons werk? Kijk 'knappe koppen' op VRT1 woensdag 4 dec 21h35 https://t.co/YRtD63kUgz
Tweet card summary image
vrt.be
Hoe kan een oude zak kamelenbloed voor een grote wetenschappelijke doorbraak zorgen? Hoe los je cold cases op met slechts één chromosoom? Kan je kanker laten wegroesten? En waarom spenderen wetensc...
0
0
7
@TomVBerghe
Tom Vanden Berghe
1 year
Another memorable CSHA ferroptosis meeting in Suzhou China. Thx to organisers and cell death community! @CSHANews #ferroptosis
0
0
11
@TomVBerghe
Tom Vanden Berghe
1 year
Big congrats to Geraldine Veeckmans for poster price award ⁦@CSHANews⁩. Let’s translate ferroptosis inhibitors to clinic! ⁦@FWOVlaanderen#ferroptosis
0
1
20
@Conrad_Lab
The Conrad Lab
1 year
Very cool - congratulations! First ferroptosis conference in the 🇺🇸 Looking forward to it!
@OlzmannLab
James Olzmann
2 years
It's official! Excited to be co-organizing the @FASEBorg conference on “Ferroptosis, Oxidative Stress, and Lipid Metabolism: From Mechanisms to Therapy” w/ Scott Dixon @SJD956 !! Next summer July 27-31 2025! Save the date. More details coming soon. 😀 #Ferroptosis #LipidTime
2
9
44
@OlzmannLab
James Olzmann
1 year
Mark your calendars! The 1st FASEB #Ferroptosis conference, July 27-31 2025! We just posted our preliminary agenda! Spectacular line up and lots of space for short talks / late breaking speakers. Help us get the word out & come join us in 2025! @FASEBorg https://t.co/VlV9L3jZHt
2
39
129
@Linkermann_Lab
Andreas Linkermann
1 year
Here is our latest review by @Mare94Fra in Cell Death & Differentiation. From a definition of #ferroptosis to clinical trial design for #ferrostatins. Great to work with @GiaccaMauro and @KingsCollegeLon on advances tharapies. @Ferroptosis2306 https://t.co/o6dLv0LHbd
Tweet card summary image
nature.com
Cell Death & Differentiation - Ferroptosis-based advanced therapies as treatment approaches for metabolic and cardiovascular diseases
0
4
22
@TomVBerghe
Tom Vanden Berghe
1 year
Check this out! Our last translational ferroptosis paper from excellent PhD student. Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease | Cell Death & Differentiation #ferroptosis #MASLD
Tweet card summary image
nature.com
Cell Death & Differentiation - Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
0
9
34
@TomVBerghe
Tom Vanden Berghe
1 year
Thankful for recognition. Broers Tom en Wim Vanden Berghe strijden met eigen therapie tegen kinderkanker: “Ik leef met leukemie dankzij nieuwe medicijnen. Nu wil ik anderen helpen” https://t.co/70heTtGYFn @HLN_BE @Stkstichting @komop_tgkanker
0
2
8